UFMylation: A Unique & Fashionable Modification for Life

Genomics, Proteomics and Bioinformatics

Volumn 14, Issue 3, 2016, Pages 140-146

  Wei, Ying ^a   Xu, Xingzhi ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

Cancer; Endoplasmic reticulum stress; Post translation modification; Ubiquitin fold modifier 1; Ubiquitin like proteins; Ufmylation

Indexed keywords

UBIQUITIN; UBIQUITIN FOLD MODIFIER 1; UNCLASSIFIED DRUG; PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE; UFC1 PROTEIN, HUMAN; UFL1 PROTEIN, HUMAN; UFM1 PROTEIN, HUMAN;

CELL FUNCTION; HUMAN; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PROTEIN FUNCTION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; UFMYLATION; ENDOPLASMIC RETICULUM STRESS; ENZYME SPECIFICITY; METABOLISM; PATHOLOGY; PROTEIN PROCESSING; UBIQUITINATION;

ENDOPLASMIC RETICULUM STRESS; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SUBSTRATE SPECIFICITY; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84973558739     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2016.04.001     Document Type: Review

References (46)

1. [1] Hsu, Y.C., Hsieh, Y.H., Liao, C.C., Chong, L.W., Lee, C.Y., Yu, Y.L., Targeting post-translational modifications of histones for cancer therapy. Cell Mol Biol (Noisy-le-grand) 61 (2015), 69–84.
2. [2] Hitosugi, T., Chen, J., Post-translational modifications and the Warburg effect. Oncogene, 33, 2014, 427985.
3. [3] Chen, Z.J., Sun, L.J., Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33 (2009), 275–286.
4. [4] Mukhopadhyay, D., Riezman, H., Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315 (2007), 201–205.
5. [5] Tompa, P., Davey, N.E., Gibson, T.J., Babu, M.M., A million peptide motifs for the molecular biologist. Mol Cell 55 (2014), 161–169.
6. [6] Herhaus, L., Dikic, I., Expanding the ubiquitin code through post-translational modification. EMBO Rep 16 (2015), 1071–1083.
7. [7] Sahtoe, D.D., Sixma, T.K., Layers of DUB regulation. Trends Biochem Sci 40 (2015), 456–467.
8. [8] Hershko, A., Ciechanover, A., The ubiquitin system. Annu Rev Biochem 67 (1998), 425–479.
9. [9] Pickart, C.M., Eddins, M.J., Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695 (2004), 55–72.
10. [10] Finley, D., Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78 (2009), 477–513.
11. [11] Wang, Y., Ladunga, I., Miller, A.R., Horken, K.M., Plucinak, T., Weeks, D.P., et al. The small ubiquitin-like modifier (SUMO) and SUMO-conjugating system of Chlamydomonas reinhardtii. Genetics 179 (2008), 177–192.
12. [12] Chung, D., Dellaire, G., The Role of the COP9 signalosome and neddylation in DNA damage signaling and repair. Biomolecules 5 (2015), 2388–2416.
13. [13] Vertegaal, A.C., Uncovering ubiquitin and ubiquitin-like signaling networks. Chem Rev 111 (2011), 7923–7940.
14. [14] Jentsch, S., Pyrowolakis, G., Ubiquitin and its kin: how close are the family ties?. Trends Cell Biol 10 (2000), 335–342.
15. [15] Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J 23 (2004), 1977–1986.
16. [16] Tatsumi, K., Sou, Y.S., Tada, N., Nakamura, E., Iemura, S., Natsume, T., et al. A novel type of E3 ligase for the Ufm1 conjugation system. J Biol Chem 285 (2010), 5417–5427.
17. [17] Yoo, H.M., Kang, S.H., Kim, J.Y., Lee, J.E., Seong, M.W., Lee, S.W., et al. Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and breast cancer development. Mol Cell 56 (2014), 261–274.
18. [18] Daniel, J., Liebau, E., The ufm1 cascade. Cells 3 (2014), 627–638.
19. [19] Kang, S.H., Kim, G.R., Seong, M., Baek, S.H., Seol, J.H., Bang, O.S., et al. Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J Biol Chem 282 (2007), 5256–5262.
20. [20] Liu, G., Forouhar, F., Eletsky, A., Atreya, H.S., Aramini, J.M., Xiao, R., et al. NMR and X-ray structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1–UBA5–UFC1 ubiquitination pathway. J Struct Funct Genomics 10 (2009), 127–136.
21. [21] Azfer, A., Niu, J., Rogers, L.M., Adamski, F.M., Kolattukudy, P.E., Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol 291 (2006), H1411–H1420.
22. [22] Zhang, Y., Zhang, M., Wu, J., Lei, G., Li, H., Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS One, 7, 2012, e48587.
23. [23] Tatsumi, K., Yamamoto-Mukai, H., Shimizu, R., Waguri, S., Sou, Y.S., Sakamoto, A., et al. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat Commun, 2, 2011, 181.
24. [24] Zhang, M., Zhu, X., Zhang, Y., Cai, Y., Chen, J., Sivaprakasam, S., et al. RCAD/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis. Cell Death Differ 22 (2015), 1922–1934.
25. [25] Cai, Y., Pi, W., Sivaprakasam, S., Zhu, X., Zhang, M., Chen, J., et al. UFBP1, a key component of the Ufm1 conjugation system, is essential for ufmylation-mediated regulation of erythroid development. PLoS Genet, 11, 2015, e1005643.
26. [26] Gannavaram, S., Connelly, P.S., Daniels, M.P., Duncan, R., Salotra, P., Nakhasi, H.L., Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of beta-oxidation of fatty acids and blocks cell division in the amastigote stage. Mol Microbiol 86 (2012), 187–198.
27. [27] Chen, C., Itakura, E., Weber, K.P., Hegde, R.S., de Bono, M., An ER complex of ODR-4 and ODR-8/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanism. PLoS Genet, 10, 2014, e1004082.
28. [28] Dou, T., Gu, S., Liu, J., Chen, F., Zeng, L., Guo, L., et al. Isolation and characterization of ubiquitin-activating enzyme E1-domain containing 1, UBE1DC1. Mol Biol Rep 32 (2005), 265–271.
29. [29] Schulman, B.A., Harper, J.W., Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 10 (2009), 319–331.
30. [30] Bacik, J.P., Walker, J.R., Ali, M., Schimmer, A.D., Dhe-Paganon, S., Crystal structure of the human ubiquitin-activating enzyme 5 (UBA5) bound to ATP: mechanistic insights into a minimalistic E1 enzyme. J Biol Chem 285 (2010), 20273–20280.
31. [31] Zheng, M., Gu, X., Zheng, D., Yang, Z., Li, F., Zhao, J., et al. UBE1DC1, an ubiquitin-activating enzyme, activates two different ubiquitin-like proteins. J Cell Biochem 104 (2008), 2324–2334.
32. [32] Homrich, M., Wobst, H., Laurini, C., Sabrowski, J., Schmitz, B., Diestel, S., Cytoplasmic domain of NCAM140 interacts with ubiquitin-fold modifier-conjugating enzyme-1 (Ufc1). Exp Cell Res 324 (2014), 192–199.
33. [33] Gannavaram, S., Davey, S., Lakhal-Naouar, I., Duncan, R., Nakhasi, H.L., Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis. PLoS Negl Trop Dis, 8, 2014, e2707.
34. [34] Watson, C.M., Crinnion, L.A., Gleghorn, L., Newman, W.G., Ramesar, R., Beighton, P., et al. Identification of a mutation in the ubiquitin-fold modifier 1-specific peptidase 2 gene, UFSP2, in an extended South African family with Beukes hip dysplasia. S Afr Med J 105 (2015), 558–563.
35. [35] Pick, E., Hofmann, K., Glickman, M.H., PCI complexes: beyond the proteasome, CSN, and eIF3 troika. Mol Cell 35 (2009), 260–264.
36. [36] Wu, J., Lei, G., Mei, M., Tang, Y., Li, H., A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem 285 (2010), 15126–15136.
37. [37] Xu, J., Wu, R.C., O'Malley, B.W., Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9 (2009), 615–630.
38. [38] Yoo, H.M., Park, J.H., Jeon, Y.J., Chung, C.H., Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer. Front Endocrinol (Lausanne), 6, 2015, 36.
39. [39] Schroder, M., Kaufman, R.J., The mammalian unfolded protein response. Annu Rev Biochem 74 (2005), 739–789.
40. [40] Hotamisligil, G.S., Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (2010), 900–917.
41. [41] Lemaire, K., Moura, R.F., Granvik, M., Igoillo-Esteve, M., Hohmeier, H.E., Hendrickx, N., et al. Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS One, 6, 2011, e18517.
42. [42] Hu, X., Pang, Q., Shen, Q., Liu, H., He, J., Wang, J., et al. Ubiquitin-fold modifier 1 inhibits apoptosis by suppressing the endoplasmic reticulum stress response in Raw264.7 cells. Int J Mol Med 33 (2014), 1539–1546.
43. [43] Hertel, P., Daniel, J., Stegehake, D., Vaupel, H., Kailayangiri, S., Gruel, C., et al. The ubiquitin-fold modifier 1 (Ufm1) cascade of Caenorhabditis elegans. J Biol Chem 288 (2013), 10661–10671.
44. [44] Liu, H., Li, J., Tillman, B., French, B.A., French, S.W., Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. Exp Mol Pathol 97 (2014), 81–88.
45. [45] Rubio, M.D., Wood, K., Haroutunian, V., Meador-Woodruff, J.H., Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia. Neuropsychopharmacology 38 (2013), 1910–1920.
46. [46] Xi, P., Ding, D., Zhou, J., Wang, M., Cong, Y.S., DDRGK1 regulates NF-κB activity by modulating IκBα stability. PLoS One, 8, 2013, e64231.